Clinical Trials Logo

Clinical Trial Summary

This study is designed to investigate the quantitative effects of sodium-free chloride supplementation on electrolyte balance, volume status, and sodium avidity in stable heart failure patients in a highly controlled environment.


Clinical Trial Description

The overarching goal of this study is to develop a comprehensive understanding of the biology and therapeutic potential of sodium-free chloride supplementation. While sodium homeostasis has been the focus of substantial investigation, very little research has been devoted to understanding chloride homeostasis. Thus, this proposal is designed to obtain the full spectrum of information pertaining to chloride, such as novel areas with great interest by the scientific community (i.e. modulation of the WNK-kinase system and the use of exosomes), to more practical/basic questions (i.e. what happens to sodium chloride balance when a patient is challenged with chloride). This study is designed as a highly controlled inpatient "GCRC" arm to be compared to a real world efficacy study that has been proposed as a separate study. With extensive biobanking and analysis of samples in the inpatient setting, we will be able to deliver a great wealth of information on the biology and therapeutic potential of manipulating chloride homeostasis in heart failure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03440970
Study type Interventional
Source Yale University
Contact Katherine Keith
Phone 8602273925
Email katherine.keith@yale.edu
Status Recruiting
Phase Early Phase 1
Start date January 15, 2019
Completion date June 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05910437 - Optimizing Treatments for Heart Failure During Hospitalization
Terminated NCT00355017 - BNP Guided Care in Addition to Multidisciplinary Care N/A
Active, not recruiting NCT03701880 - Early Use of Ivabradine in Heart Failure N/A
Recruiting NCT03157219 - Manipal Heart Failure Registry (MHFR) N/A
Recruiting NCT06114498 - Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
Completed NCT03838003 - Exercise in Patients Admitted With Recently Decompensated Heart Failure N/A
Recruiting NCT02997462 - Monocyte Phenotypic Changes in Heart Failure
Completed NCT04493346 - Shear Wave Elastography
Recruiting NCT02666651 - Regional Tolvaptan Registry Phase 4
Recruiting NCT02236247 - Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure Phase 1/Phase 2
Not yet recruiting NCT06273397 - Acetazolamide or Metolazone in Acute Heart Failure N/A
Recruiting NCT06286423 - Colchicine in Acutely Decompensated HFREF Phase 4
Completed NCT05927285 - Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1 N/A
Withdrawn NCT04572867 - Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure N/A
Completed NCT02157506 - A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure Phase 2
Recruiting NCT03914222 - Comparing PA Compliance During and After Decompensation in HFP N/A
Recruiting NCT03009552 - Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure N/A
Completed NCT04019314 - Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI) N/A
Recruiting NCT02649517 - Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction N/A
Recruiting NCT05090930 - Innovative Technologies for the Treatment of Pulmonary and Heart Failure N/A